Tocqueville Asset Management L.P. Buys 42,277 Shares of Healthpeak Properties, Inc. $DOC

Key Points

• Tocqueville Asset Management L.P. has increased its stake in Healthpeak Properties by 23.0%, owning 226,482 shares valued at $4,579,000 as of its latest SEC filing.
• CEO Scott M. Brinker and Director Tommy G. Thompson have made recent stock purchases, indicating confidence in the company's future.
• Healthpeak Properties reported earnings per share (EPS) of $0.46 for the last quarter, matching analyst expectations, but revenue slightly fell short by 0.2% year-over-year.

Tocqueville Asset Management L.P. increased its stake in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 23.0% in the first quarter, according to its most recent 13F filing with the SEC. The firm owned 226,482 shares of the real estate investment trust's stock after purchasing an additional 42,277 shares during the period. Tocqueville Asset Management L.P.'s holdings in Healthpeak Properties were worth $4,579,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in DOC. TCTC Holdings LLC raised its holdings in shares of Healthpeak Properties by 124.3% in the 1st quarter. TCTC Holdings LLC now owns 1,355 shares of the real estate investment trust's stock valued at $27,000 after purchasing an additional 751 shares in the last quarter. Future Financial Wealth Managment LLC acquired a new stake in Healthpeak Properties during the 1st quarter worth $30,000. S.A. Mason LLC raised its stake in Healthpeak Properties by 160.9% during the 1st quarter. S.A. Mason LLC now owns 1,500 shares of the real estate investment trust's stock worth $30,000 after acquiring an additional 925 shares in the last quarter. Dagco Inc. acquired a new stake in Healthpeak Properties during the 1st quarter worth $30,000. Finally, GKV Capital Management Co. Inc. acquired a new stake in Healthpeak Properties during the 1st quarter worth $36,000. Hedge funds and other institutional investors own 93.57% of the company's stock.

Insider Buying and Selling at Healthpeak Properties

In other news, CEO Scott M. Brinker bought 2,930 shares of the firm's stock in a transaction that occurred on Thursday, July 31st. The stock was acquired at an average cost of $17.06 per share, with a total value of $49,985.80. Following the completion of the purchase, the chief executive officer owned 210,416 shares of the company's stock, valued at $3,589,696.96. This represents a 1.41% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Tommy G. Thompson bought 5,777 shares of the firm's stock in a transaction that occurred on Wednesday, May 28th. The stock was purchased at an average cost of $17.27 per share, with a total value of $99,768.79. Following the completion of the purchase, the director directly owned 144,290 shares of the company's stock, valued at $2,491,888.30. This represents a 4.17% increase in their position. The disclosure for this purchase can be found here. Insiders purchased 14,560 shares of company stock valued at $249,898 over the last three months. 0.23% of the stock is owned by company insiders.

Healthpeak Properties Stock Up 0.4%

NYSE DOC traded up $0.0650 during trading hours on Thursday, reaching $17.2850. 5,375,594 shares of the company's stock were exchanged, compared to its average volume of 6,068,607. The company has a market capitalization of $12.01 billion, a price-to-earnings ratio of 72.02, a price-to-earnings-growth ratio of 2.20 and a beta of 1.05. Healthpeak Properties, Inc. has a one year low of $16.63 and a one year high of $23.26. The company's 50-day moving average is $17.62 and its two-hundred day moving average is $18.42. The company has a debt-to-equity ratio of 1.06, a quick ratio of 1.28 and a current ratio of 1.28.

Healthpeak Properties (NYSE:DOC - Get Free Report) last issued its quarterly earnings results on Thursday, July 24th. The real estate investment trust reported $0.46 earnings per share for the quarter, hitting the consensus estimate of $0.46. The company had revenue of $694.35 million during the quarter, compared to analysts' expectations of $697.14 million. Healthpeak Properties had a net margin of 5.90% and a return on equity of 1.85%. The business's quarterly revenue was down .2% on a year-over-year basis. During the same period last year, the business earned $0.45 EPS. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. On average, analysts forecast that Healthpeak Properties, Inc. will post 1.86 EPS for the current fiscal year.

Healthpeak Properties Dividend Announcement

The firm also recently declared a dividend, which will be paid on Friday, August 29th. Stockholders of record on Tuesday, August 19th will be paid a dividend of $0.1017 per share. This represents a dividend yield of 705.0%. The ex-dividend date of this dividend is Monday, August 18th. Healthpeak Properties's dividend payout ratio (DPR) is currently 508.33%.

Analysts Set New Price Targets

A number of research analysts have commented on DOC shares. Deutsche Bank Aktiengesellschaft restated a "hold" rating and issued a $18.00 price objective (down from $28.00) on shares of Healthpeak Properties in a research note on Wednesday. Scotiabank downgraded shares of Healthpeak Properties from a "sector outperform" rating to a "sector perform" rating and cut their target price for the company from $21.00 to $19.00 in a research note on Tuesday, July 29th. Evercore ISI decreased their price objective on shares of Healthpeak Properties from $23.00 to $21.00 and set an "outperform" rating for the company in a report on Monday, April 28th. Wedbush cut their price objective on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating on the stock in a research report on Monday, April 28th. Finally, Argus reiterated a "buy" rating and issued a $25.00 target price on shares of Healthpeak Properties in a report on Tuesday, April 29th. Seven research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $22.09.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.